Xeomin 200 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FFK8J
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,010
Award facts
- Contract value 100% obligated
- $18,010.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 15, 2026, the Defense Logistics Agency awarded a delivery order valued at $18,010.20 to AmerisourceBergen Drug Corp for the supply of XEOMIN 200 Unit Vials, with performance scheduled to be completed by February 6, 2026. This non-competitive, firm fixed-price delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The work will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters and serves as a critical pharmaceutical distributor for federal medical procurement needs.
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., operates as one of the primary vendors supporting military and federal healthcare systems through comprehensive pharmaceutical supply delivery. The company's extensive federal contract portfolio demonstrates its capability to supply a wide range of medical products, including specialty medications, vaccines, and medical devices across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This specific delivery order for XEOMIN, a botulinum toxin preparation commonly used in medical and military healthcare settings, exemplifies the routine pharmaceutical resupply operations conducted through the DLA's established pharmaceutical prime vendor contracts.
Quick answers
Who was awarded contract SPE2DR26FFK8J?
SPE2DR26FFK8J was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FFK8J worth?
The government has obligated $18,010 on SPE2DR26FFK8J.
Is contract SPE2DR26FFK8J an order under another contract?
Yes. SPE2DR26FFK8J is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFK8J competed?
The extent of competition for SPE2DR26FFK8J was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award